Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,490
Closed -$128K 113
2022
Q4
$128K Hold
2,490
0.1% 75
2022
Q3
$109K Sell
2,490
-420
-14% -$20.4K 0.09% 79
2022
Q2
$153K Hold
2,910
0.12% 72
2022
Q1
$151K Hold
2,910
0.09% 81
2021
Q4
$172K Buy
+2,910
New +$144K 0.09% 79

Other funds holding PFE

WD Rutherford's PFE Position: Q1 2023 in Review

WD Rutherford sold out of Pfizer (PFE) in Q1 2023, closing a stake of 2,490 shares — an estimated $128K sold.

WD Rutherford first reported a position in PFE in Q4 2021 and held it in 5 quarters. The position peaked at $172K in Q4 2021. 3,102 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

  • WD Rutherford reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
  • WD Rutherford sold 2,490 Pfizer shares in Q1 2023, an estimated $128K.
  • WD Rutherford first reported a position in Pfizer in Q4 2021 and held it in 5 quarters.
  • WD Rutherford's Pfizer position peaked at $172K in Q4 2021.
  • 3,102 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on WD Rutherford's 13F filing for Q1 2023, filed 11 Apr 2023.